...after another sGC stimulator failed in a different population of HF patients. On Oct. 30, Cyclerion Therapeutics Inc....

...Ironwood. Despite the miss for praliciguat, the company sees signs of optimism for the platform. Cyclerion Therapeutics Inc....
...this tells us that we’re hitting the right range,” Currie told BioCentury. Erin McCallister, Senior Editor Praliciguat, IW-1973 Cyclerion Therapeutics Inc. Soluble...

...model, praliciguat decreased steatosis and levels of a marker of liver fibrosis. Next steps by Cyclerion Therapeutics Inc....
...doi:10.1073/pnas.1821045116 CONTACT: Katherine C. Hall, Ironwood Pharmaceuticals Inc. and Cyclerion Therapeutics Inc., Cambridge, Mass. e-mail: khall@cyclerion.com Sandi Wong Praliciguat, IW-1973 Cyclerion Therapeutics Inc. Soluble...

...Ironwood-spinout Cyclerion is making the case for extending its lead sGC stimulator praliciguat into NASH. Cyclerion Therapeutics Inc....
...optimize pharmacology but has not chosen a specific liver indication, Wright added. Sandi Wong, Staff Writer Praliciguat, IW-1973 Cyclerion Therapeutics Inc. Ironwood...

...pipeline for at least two years (see "Ironwood Spinout Cyclerion Planning $175M Private Placement" ). Cyclerion Therapeutics Inc....
...Pharmaceuticals Inc. (NASDAQ:IRWD) retains its gastrointestinal business (see "Splitting Ironwood" ). Mary Romeo, Staff Writer IW-6463 olinciguat (IW-1701) Praliciguat, IW-1973 Cyclerion Therapeutics Inc. Ironwood...

...Peter Hecht and President and CSO Mark Currie. In conjunction with its April 2 launch, Cyclerion Therapeutics Inc....
...as CEO. He was an independent non-executive member of the board. BioCentury Staff Alder BioPharmaceuticals Inc. Alkermes plc Chimerix Inc. Cyclerion Therapeutics Inc. Polyphor...

...Ironwood was off $0.43 to $14.08 on Feb. 26. Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Cambridge, Mass. Cyclerion Therapeutics Inc....

...Ironwood was off $0.43 to $14.08 on Tuesday. Hongjiang Li IW-1701 IW-6463 Praliciguat, IW-1973 Ironwood Pharmaceuticals Inc. Soluble guanylate cyclase (sGC) Cyclerion Therapeutics Inc....

...Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) named Mark Currie as incoming president of its spinout Cyclerion Therapeutics Inc. Currie will...

...GI company said co-founder and CEO Peter Hecht will become CEO of the company's spinout Cyclerion Therapeutics Inc....